FreezeM
FreezeM54
About
What does FreezeM do?
FreezeM provides life-cycle paused Black Soldier Fly (BSF) neonates, called PauseM®, to insect farming operations. Their patented technology allows for the decoupling of BSF reproduction from rearing and processing, enabling customers to achieve higher protein production yields and reduced operational costs. FreezeM serves insect farms globally seeking efficient and scalable BSF breeding solutions.
What is FreezeM's revenue?
StartupHub estimates FreezeM's annual revenue at $5.3M (range $2.9M to $7.8M, 64% confidence), based on comparable companies in the sector.
What is FreezeM's valuation?
StartupHub estimates FreezeM's effective valuation at $85.1M (range $52.1M to $125.2M, 12% confidence), based on comparable companies in the sector.
How much funding has FreezeM raised?
FreezeM has raised a total of $21M in funding. The most recent round on record is Series A.
Where is FreezeM headquartered?
FreezeM is headquartered in Tel Aviv, Israel.
When was FreezeM founded?
FreezeM was founded in 2018.
What industry does FreezeM operate in?
FreezeM operates in Biotech, Insects, AgTech, FoodTech, Insect Protein, Sustainability.
How many employees does FreezeM have?
FreezeM has approximately 29 people on record.
No comments yet. Be the first to share your take.